SECOND AMENDMENT TO SECOND AMENDED AND RESTATED COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • November 5th, 2020 • Regulus Therapeutics Inc. • Pharmaceutical preparations
This Second Amendment to Second Amended and Restated Collaboration and License Agreement (“Second Amendment”) is made and entered into as of the date of the last signature below(the “Second Amendment Date”), by and between Sanofi, a company organized under the laws of France (“Sanofi”) having a place of business at 54, rue la Boétie, 75008, Paris, France, registered in the Paris Trade and Company Register under no. 395 030 844, and Regulus Therapeutics Inc., a corporation organized under the laws of the State of Delaware, USA (“Regulus”) having a place of business at 10628 Science Center Drive, Suite 225, San Diego, California 92121, USA. Sanofi and Regulus each may be referred to herein individually as a “Party,” or collectively as the “Parties.”
Property shall continue to be part of Collateral. The parties hereby agree that Section 6 of the Eighth Amendment is hereby made null and void. “Eighth Amendment” is that certain Eighth Amendment to the Loan and Security Agreement, entered into by the...Loan and Security Agreement • November 5th, 2020 • Regulus Therapeutics Inc. • Pharmaceutical preparations
